Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Datametrex AI Ltd V.DM

Alternate Symbol(s):  DTMXF

Datametrex AI Limited is a technology-focused company with exposure to artificial intelligence, healthcare, and mobile gaming. It is focused on collecting, analyzing and presenting structured and unstructured data using machine learning and artificial intelligence. The Company's products include AnalyticsGPT, Cyber Security, and Healthcare. AnalyticsGPT platform scans vast data streams from... see more

TSXV:DM - Post Discussion

Datametrex AI Ltd > HC approval guesses?
View:
Post by forthemoney on Oct 06, 2020 11:55am

HC approval guesses?

Anyone out there thinking that we'll see our test kits approved by HC this week?

Wishful thinking?  Or do you think they've given themselves a Thanksgiving deadline to aim for?

Thoughts ...

GLTA

eom
Comment by Leonovus2017 on Oct 06, 2020 12:29pm
I am thinking it will likely get dragged out as they have not looked at it. Obviously would have been approved in a pandemic. There must be something else they want to approve... HC is strange as they are not helping reduce the spread very well. If they thought the Ionebio was the best out there, it would be approved months ago. Something is fishy... I hope DM focuses on the world to bring more ...more  
Comment by Surathani on Oct 06, 2020 2:27pm
The problem is that the game is rigged against small companies and start-ups in favour of large pharmaceutical companiess like Abbot.  Why else would two of Abbotts devices get approvals first and back-to-back.  Abbott, I am sure has alot of money to throw around to greece those dirty palms of unscrupilus politicians, political parties, and senior public servants. Getting very ...more  
Comment by Trusted91 on Oct 06, 2020 6:38pm
Exactly how do you think these politicians amass such great wealth on an mp salary   They make their money through influence.  Regardless nothing stops DM s AI business from prosperity and the market for tests in the EU and USA etc is far greater than Canada. Also JT loves China so not sure South Korean tests (even though they are the gold standard) have a chance !!  Sad the corrupt ...more  
Comment by Dejos74 on Oct 06, 2020 8:16pm
I should have spevcified who I meant as lobbyist's for the company that were added to the board and the Medical Advisory Board such as, Dr. Alexander MacGregor, Ph.D,  Benj Gallander,  Hon. James S. Peterson, P.C, Todd Shapiro, and others that were supposed to help market and lobby the gov's for approval and sales.  I will be considering my votes very ...more  
Comment by Dejos74 on Oct 06, 2020 2:50pm
I'm still trying to figure out what our lobbyist's are doing for their money.
Comment by Pandora on Oct 06, 2020 2:56pm
They appear to be afraid to make a decision of their own. It's easier to ride on the coat tails of the Americans and then if anything isn't right they can say well we followed their decision.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities